Estrogen decreases tight junction protein ZO-1 expression in human primary gut tissues

Copyright © 2017 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 183(2017) vom: 01. Okt., Seite 174-180
1. Verfasser: Zhou, Zejun (VerfasserIn)
Weitere Verfasser: Zhang, Lumin, Ding, Miao, Luo, Zhenwu, Yuan, Shao, Bansal, Meena B, Gilkeson, Gary, Lang, Ren, Jiang, Wei
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2017
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't Sex differences ZO-1 estrogen gut tissues Estrogen Receptor alpha Estrogen Receptor beta mehr... Interleukin-6 NF-kappa B TJP1 protein, human Zonula Occludens-1 Protein Estradiol 4TI98Z838E Keratins 68238-35-7
LEADER 01000naa a22002652 4500
001 NLM275393704
003 DE-627
005 20231225005557.0
007 cr uuu---uuuuu
008 231225s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2017.08.019  |2 doi 
028 5 2 |a pubmed24n0917.xml 
035 |a (DE-627)NLM275393704 
035 |a (NLM)28867253 
035 |a (PII)S1521-6616(17)30375-3 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Zhou, Zejun  |e verfasserin  |4 aut 
245 1 0 |a Estrogen decreases tight junction protein ZO-1 expression in human primary gut tissues 
264 1 |c 2017 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 13.12.2017 
500 |a Date Revised 13.11.2018 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2017 Elsevier Inc. All rights reserved. 
520 |a Females have a higher prevalence of most autoimmune diseases; however, the mechanism is unknown. In this study, we examined the expression of tight junction protein zonula occludens 1 (ZO-1) and estrogen receptor (ER)-α/β in human primary gut tissues by immunohistochemistry, immunofluorescence and qPCR. The expression of ZO-1 and ER-β but not ER-α was present in both male and female gut tissues. There was no sex difference in ER-β expression, but ZO-1 expression was decreased in females compared to males. In vitro, estrogen treatment decreased ZO-1 mRNA and protein expression, ZO-1 promoter activity, IL-6 production, and NF-κB activation in human primary gut tissues or the Caco-2 cells, but increased the ER-β expression in Caco-2 cells. Consistently, plasma IL-6 levels in females were reduced relative to males in vivo. Our finding indicates that estrogen may play a role in gut tight junction expression and permeability 
650 4 |a Journal Article 
650 4 |a Research Support, N.I.H., Extramural 
650 4 |a Research Support, U.S. Gov't, Non-P.H.S. 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Sex differences 
650 4 |a ZO-1 
650 4 |a estrogen 
650 4 |a gut tissues 
650 7 |a Estrogen Receptor alpha  |2 NLM 
650 7 |a Estrogen Receptor beta  |2 NLM 
650 7 |a Interleukin-6  |2 NLM 
650 7 |a NF-kappa B  |2 NLM 
650 7 |a TJP1 protein, human  |2 NLM 
650 7 |a Zonula Occludens-1 Protein  |2 NLM 
650 7 |a Estradiol  |2 NLM 
650 7 |a 4TI98Z838E  |2 NLM 
650 7 |a Keratins  |2 NLM 
650 7 |a 68238-35-7  |2 NLM 
700 1 |a Zhang, Lumin  |e verfasserin  |4 aut 
700 1 |a Ding, Miao  |e verfasserin  |4 aut 
700 1 |a Luo, Zhenwu  |e verfasserin  |4 aut 
700 1 |a Yuan, Shao  |e verfasserin  |4 aut 
700 1 |a Bansal, Meena B  |e verfasserin  |4 aut 
700 1 |a Gilkeson, Gary  |e verfasserin  |4 aut 
700 1 |a Lang, Ren  |e verfasserin  |4 aut 
700 1 |a Jiang, Wei  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 183(2017) vom: 01. Okt., Seite 174-180  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:183  |g year:2017  |g day:01  |g month:10  |g pages:174-180 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2017.08.019  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 183  |j 2017  |b 01  |c 10  |h 174-180